# Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms — Recommendations for Clinical Evaluation - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/estrogen-and-estrogenprogestin-drug-products-to-treat-vasomotor-symptoms-and-vulvar-and-vaginal-atrophy-symptoms-recommendations-for-clinical-evaluation/729d676c-05c7-4f9b-bfcd-77ed841b485f

> FDA guidance document: Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms — Recommendations for Clinical Evaluation. Issue date: January 31, 2003. Get complete insights and analysis.

---

## Details

- Title: Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms — Recommendations for Clinical Evaluation
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2003-01-31
- Last Changed: 2019-03-13

## Related Documents

- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [Mpox: Development of Drugs and Biological Products; Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/mpox-development-of-drugs-and-biological-products-guidance-for-industry/ef1c9a82-c229-49ef-a357-d9947fb4dcdb)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)